The Gem Transaction (Details) |
Dec. 31, 2018
USD ($)
|
|---|---|
| Business Combinations [Abstract] | |
| Cash recorded on the Company's Balance Sheet | $ 5,000,000 |
| Assembled Workforce recorded as In-process Research and Development Expense on the Company's Statement of Operations | 9,886 |
| Camsirubicin (GPX-150) recorded as In-process Research and Development Expense on the Company's Statement of Operations | 13,491,736 |
| Total Gem Transaction | $ 18,501,622 |
| X | ||||||||||
- Definition Amount of assets acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|